Publications by the researcher in collaboration with Antonio García Honrubia (16)

2016

  1. Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy

    European Journal of Clinical Investigation, Vol. 46, Núm. 2, pp. 123-129

2015

  1. Importance of sudden cardiac death risk stratification in hypertrophic cardiomyopathy

    Revista Espanola de Cardiologia

  2. Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy

    Journal of Internal Medicine, Vol. 278, Núm. 1, pp. 50-58

2014

  1. Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy

    QJM, Vol. 107, Núm. 8, pp. 613-621

2013

  1. Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches

    Annals of Medicine, Vol. 45, Núm. 4, pp. 341-347

2012

  1. Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy

    European Journal of Internal Medicine, Vol. 23, Núm. 2, pp. 169-174

2011

  1. Collagen peptides, interstitial remodelling and sudden cardiac death in hypertrophic cardiomyopathy

    Clinical Chemistry and Laboratory Medicine

2010

  1. Plasma levels of Von Willebrand factor are increased in patients with hypertrophic cardiomyopathy

    Thrombosis Research, Vol. 126, Núm. 1

  2. Serum Levels of high-sensitivity troponin T: A novel marker for cardiac remodeling in hypertrophic cardiomyopathy

    Journal of Cardiac Failure, Vol. 16, Núm. 12, pp. 950-956

2009

  1. ¿Existe un efecto beneficioso a largo plazo con el tratamiento con marcapasos de la miocardiopatía hipertrófica obstructiva severa?

    Revista Espanola de Cardiologia, Vol. 62, Núm. 11, pp. 1233-1239

2008

  1. Cardiorresonancia magnética con gadolinio y capacidad de esfuerzo en la miocardiopatía hipertrófica

    Revista Espanola de Cardiologia, Vol. 61, Núm. 8, pp. 853-860

  2. Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk

    Annals of Medicine, Vol. 40, Núm. 7, pp. 553-559

  3. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy

    American Heart Journal, Vol. 156, Núm. 1, pp. 85-91

  4. Reply

    Journal of the American College of Cardiology

2007

  1. Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 50, Núm. 25, pp. 2399-2403

2006

  1. Antiplatelet versus anticoagulant therapies in advanced age: An unfinished task

    International Journal of Cardiology, Vol. 110, Núm. 2, pp. 271-272